In this photo: Ayan Dasgupta, Gabriella Dweck, Shaily Shah, Brian D'Agostino, Wanrui Zhang, James T. Shoemaker, Jelena Vukasinovic, and Rubin Reisler
President and CEO
Ms. Vukasinovic is the Chief Executive Officer and President at Lena Biosciences. She is a proven inventor and a successful entrepreneur. Jelena has a solid track record of bringing innovative products to market backed by fifteen years of experience in medical devices, biotechnology, and life sciences. She secured financing for corporate growth, developed and protected intellectual property, and assembled an outstanding team of experienced engineers, scientists, partners, and collaborators to streamline the company's operations. Her technology developments have been funded by the small business grant awards from the National Institutes of Health, the National Science Foundation, and the Georgia Research Alliance Venture Lab. Prior to forming Lena Biosciences, Jelena served as research faculty at Georgia Tech for over ten years. Jelena holds a M.S. in Mechanical Engineering from the Georgia Institute of Technology.
Chief Science Officer
james t. shoemaker
Dr. Shoemaker is an accomplished biomedical engineer with ten years of experience in development and application of three-dimensional (3D) tissue models in applied research and pharmaceutical testing. James is responsible for 3D cell-based assays, pre-clinical device R&D, scientific collaborations and partnering activities. He has published peer-reviewed articles focusing on tissue engineering, biomedical devices and biomaterials, and frequently presents at conferences and symposiums. James has developed an extraordinary number of forefront tissue models, using primary cells, secondary cells, and cell lines, spanning normal tissue models (brain, liver, kidney, bone, etc.) and diseased tissue models (neuroblastoma, cervical cancer, breast cancer, hepatoma, etc). Prior to joining Lena Biosciences, James research positions at Emory University. Dr. Shoemaker holds a Ph.D. in Biomedical Engineering from Emory University and the Georgia Institute of Technology and a B.Sc. in Chemistry from the Georgia Institute of Technology.
Member of the Board of Directors
joseph l. beverly
Mr. Beverly is a strategic partner and a member of the Board of Directors at Lena Biosciences. He is an experienced entrepreneur with over twenty five years of C-level, board member, and senior management experience in leading early-stage financial technology and health/family care companies to profitability or acquisition. He is the Chairman of the Board of Directors and President at Adaptable Systems Corporation, doing business as Corporate Payroll Services, which he founded and has managed since its inception. His specialties include business formation, business development, corporate governance, mergers and acquisitions, sales and marketing, strategic planning, and investments. Mr. Beverly holds a B.A. in Business Administration from the University of Georgia, Terry College of Business.
Dr. LaPlaca is an Associate Professor in the Coulter Department of Biomedical Engineering at Emory University and the Georgia Institute of Technology and currently serves as Director of the Laboratory for Neuroengineering. She is also on the Editorial Board of the Journal of Neurotrauma. Her research interests are in traumatic brain injury and injury biomechanics, specifically in cellular injury tolerances, biomarkers, mechanistically-driven neuroprotective strategies, and cognitive impairment. She has published over 60 peer-reviewed papers and her research has been funded by the National Institute of Health, the National Science Foundation, the Department of Defense, and the Coulter Foundation. She received an NSF CAREER award (2000), the 2007 Atlanta Business Chronicle Healthcare Heroes Award for Healthcare Innovation, and is an elected fellow in the American Institute for Medical and Biological Engineering (AIMBE).